Ankyrin Repeat Domain 1 Overexpression is Associated with Common Resistance to Afatinib and Osimertinib in EGFR-mutant Lung Cancer

Akiko Takahashi(Japan Agency for Medical Research and Development), Akihiko Gemma(Nippon Medical School)
Scientific Reports
October 1, 2018
Cited by 56


Related Papers